New Year Resolutions, New Laws: Real Change for You & the Industry

• Dr. Joan Irvine is a noted author, cannabis educator, and someone who has truly mastered the art of making small shifts that lead to healthy habits.  A longtime advocate for online privacy, digital safety, and ethical business practices. With a background in psychology and extensive experience in compliance, technology policy, and consumer protection, she has worked to create safer digital spaces while promoting responsible innovation. Dr. Irvine’s expertise spans from regulatory frameworks to corporate responsibility, making her a valuable voice in discussions on cannabis, wellness, and industry ethics.
• Dr. Manesh Girn is a neuroscientist and researcher specializing in the effects of psychedelics and cannabis on the brain. With a PhD in Neuroscience, he explores how these substances impact cognition, mental health, and overall well-being. Dr. Girn is passionate about bridging scientific research with real-world applications, helping to reshape the conversation around plant medicine.
• Walter Chad Blackhum is an Associate Attorney at MacMurray & Shuster and an expert and advocate in the cannabis industry. With years of experience navigating the complex regulatory landscape, he focuses on expanding access to cannabis, promoting responsible policies, and supporting small businesses in this ever-evolving market.

• Start Making Sense: What Does Schedule III & Section 280E Mean for Me?
• Drug Enforcement Administration DEA to hold hearing on Rescheduling Marijuana (Media Advisory, Nov 2024)
• NCIA Only Pro-Cannabis Organization Granted Standing in DEA Rescheduling Proceedings by Aaron Smith (Nov 2024)
• Update on the DEA's efforts to reschedule cannabis: what you need to know by Alex Malyshev and Sarah Ganley (Reuters Sept 2024)
• Cannabis stocks drop sharply as DEA sets drug-rescheduling hearing after November election by Steve Gelsi (MarketWatch Aug 2024)
• FDA Concludes that a New Regulatory Pathway for CBD is Needed (2023)

Take Action

• Take Action: Oppose the No Deductions for Marijuana Businesses Act!

Confusion Over Cannabinoids

• Grand View Research: Cannabidiol (CBD) Market Size, Share & Trends Analysis Report, 2023-2030
• Brightfield Group: Delta-8 THC Market Report,  (Whitepaper 2022) - Note: Access to this report may require a subscription or purchase.

Hemp-Derived Product Safety Issue

• FDA: Warning Letters and Test Results for Cannabidiol-Related Products

Economic Challenges for Hemp Farmers

• Hemp Benchmarks: Hemp Industry Reports - Note: Access to this report may require a subscription or purchase.
• Vote Hemp: Vote Hemp is a leading advocacy organization for hemp farming in the U.S. They have published various reports on hemp cultivation and licensing. While specific Reports aren't directly linked, you can access reports through their newsroom. Additionally, the USDA published the 2021 National Hemp Report, estimating the value of hemp production in the U.S. at $824 million. For more details see Vote Hemp's coverage of this report.

• Mix Up Your Mocktails With a CBD Drink Mix with Dr. Joan Irvine 
• Cannabis, Psychedelics and Brain Health with Dr. Manesh Girn
• Lighting the Path: Hanukkah & Kosher Cannabis with Rabbi Yaakov Cohen & 253 Farmacy Founders
• From Rules to Reality: Cannabis in Practice with Walter Chad Blackham